+147.3%
MPWR vs GSK
+62.2%
+85.1%
-51.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.8% | -1.9% | +2.8% | +1.0% |
| 7D | -2.6% | -1.8% | -0.7% | -2.4% |
| 30D | -9.0% | -2.2% | -6.9% | -8.9% |
| 3M | -25.8% | -1.8% | -24.0% | -26.0% |
| 6M | +11.8% | -10.6% | +22.4% | +13.5% |
| YTD | +35.5% | +4.4% | +31.1% | +33.9% |
| 1Y | +45.3% | +30.4% | +14.9% | +37.3% |
| All | +147.3% | +62.2% | +85.1% | +130.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling